Sima Boulebatt Mahfoud

Sima Boulebatt Mahfoud

Auto-generated profile, based on publicly available information

Sima Boulebatt Mahfoud

MD National Hospital Center (CHN) of Nouakchott -Mauritania

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2023 in Journal of Multidisciplinary Applied Natural Science
Verified
Journal Article
Open access
PDF file
SMSima Boulebatt Mahfoud
Sima Boulebatt Mahfoud
HOHamid EL Oirdi
Hamid EL Oirdi
EMEl Hafedh El Mouhab
El Hafedh El Mouhab
NANasser Abdellahi
Nasser Abdellahi
FAFeil Ahmed
Feil Ahmed
DBDriss BELGHYTI
Driss BELGHYTI
Malnutrition is a worldwide concern with worrisome outcomes that affect substantially the lifestyle of infants. The main aim is to investigate the efficacy of the IMSAM protocol over malnourished Mauritanian children during hospitalization. A cohort of 230 participants, including 126 boys and 104 girls collected from rural and urban areas with an average age of 15.52 ± 7.727 months were enrolled. The study is carried out in the Pediatric Service of the National Hospital Center of Nouakchott, Mauritania on children who have undergone the national protocol for the Integrated Management of Severe Acute Malnutrition (IMSAM). In addition, the medical and nutritional treatment, and body measurements were appreciated as well as the anthropometric parameters. The findings exhibit during nutritional-based intervention significant differences between the mean of weight during the pre- and post-intervention (P < 0.001). Moreover, through a regression test, we found a negatively predicted weight gain (P < 0.05) by the variables Z-score of weight to height (P / T) Edema after Nutritional Support and final health status. Last, but by no means least, the IMSAM-based intervention with rational management might make inroads into mitigating adverse outcomes of malnutrition through maximizing social skills.

25 June 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
FAFatima Aslaou
Fatima Aslaou
NANajat Ababsi
Najat Ababsi
HIHalima Ibrahimi
Halima Ibrahimi
SBSima M. Boulebatt
Sima M. Boulebatt
MNMy Abdellah Nabaoui
My Abdellah Nabaoui
HAHefdhallah Saad Al-AIZARI
Hefdhallah Saad Al-AIZARI
The aim of the analyze the risk factors for the main causes of early neonatal mortality in Morocco. At the national level, Intrauterine hypoxia, prematurity, perinatal infection and neonatal jaundice account for 90% of neonatal deaths in Morocco. Intrauterine hypoxia, prematurity, perinatal infection and neonatal jaundice account for 90% of neonatal deaths in Morocco. Factors associated with intrauterine hypoxia include: maternal anemia (OR :1.8 CI to 95% :1.5,3.2), placental infarction (OR :1.2 CI to 95%:1.1,2.2), parental smoking (OR :3.9 CI to95% :3.2,6.9), intrauterine growth retardation (OR :5. 6 CI to 95% :5.1,7.3) and gestational diabetes (OR :4.9, CI to95% :5.01,7.5), with regard to neonatal jaundice, the risk factors gravitate around hyperbilirubinemia (OR :1.6 CI to95% :1.2,2.5), premature birth less than 37weeks (OR :4. 6 CI to95% :3.4,7.1), congenital hemolytic anemia (OR :3.2 CI to 95% :3.1,4.2), and blood group incompatibility (OR :2.4 CI to 95% :2.2,3.9). For risk factors of perinatal infection, the study highlighted the association with maternal age less than 25years (OR :3. 5 CI to 95% :2.7,4.3), bacterial vaginosis (OR :4.2 CI to 95% :3.9,7.5), Placenta Preavia (OR :7.2 CI to 95% :5.3,8.5), and prenatal consultation frequency less than two visits (OR :6.4 CI to 95% :5.2,6.9. With regard to risk factors for neonatal infection, Escherichia coli, isolated by Cyto-Bacteriological examination, was the cause of 973 (31.9%) neonatal infections. The study highlighted several factors: premature rupture of membranes beyond 12 hours, (OR:5. 4 CI to 95%:4.2,6.3), gestational age less than 37 weeks of amenorrhea (OR:4.6 CI to 95%:3.4,7.1), on the other hand, cesarean section was a protective factor against perinatal infection (OR:0.3 CI to 95%:0.1,0.4). Screen and treat maternal anemia; educate on smoking cessation; manage gestational diabetes; monitor fetal growth. Identify and manage hyperbilirubinemia; care for premature infants; screen for hemolytic anemia; test blood group compatibility. Promote maternal health; screen for bacterial vaginosis; manage placenta previa; increase prenatal consultations. Manage membrane rupture; care for premature infants; use cesarean sections when needed; ensure neonatal hygiene.